Company Overview
Aflac Incorporated operates primarily within the Financial Services sector, specifically focusing on the Insurance - Life industry by providing supplemental health and life insurance products through its subsidiary network. The company manages operations across two distinct segments, Aflac Japan and Aflac U.S., offering a diverse portfolio that includes cancer, medical, nursing care, whole life, GIFT insurance products, as well as WAYS and child endowment plans. This entity maintains a substantial market capitalization of $55.77B, supported by an annual revenue stream of $17.16B and a workforce comprising 12,716 employees. These valuation and revenue figures indicate that Aflac holds a significant position within the supplemental insurance market, reflecting a large-scale enterprise capable of generating multi-billion dollar operational flows.
Financial Health
The company reported a trailing twelve-month revenue of $17.16B with a corresponding net income of $3.65B and an EBITDA of $4.79B. The substantial gap between the $17.16B revenue and $3.65B net income reveals a cost structure where expenses, including claims and operating costs, consume a significant portion of gross inflows before reaching the bottom line. Free cash flow stands at $5.18B, which provides the organization with robust financial flexibility to fund operations, service debt, or return capital to shareholders without compromising liquidity. Gross margin is recorded at 46.6%, indicating the efficiency of the primary insurance business before overhead, while operating margin reaches 33.6% to show profitability after internal expenses, and profit margin sits at 21.2% to reflect the final earnings quality relative to sales. The balance sheet holds $7.63B in cash against $12.59B in debt, resulting in a debt-to-equity ratio of 42.68, which suggests a leveraged capital structure where debt obligations exceed cash reserves. Current ratio is 1.07, indicating that current assets slightly exceed current liabilities and signaling a baseline level of short-term liquidity that is tight but functional. Return on equity is 13.1% and return on assets is 2.5%, metrics that reveal management effectiveness in generating shareholder value relative to equity and utilizing total assets to produce earnings.
Valuation Assessment
The stock trades with a trailing P/E ratio of 15.60 and a forward P/E of 13.70, implying that the market expects earnings to recover or grow in the future given the lower forward multiple compared to the trailing figure. The price-to-book ratio is 1.87, indicating that the market values the company at a moderate premium over its book value, reflecting intangible assets like brand reputation and future cash flows. Price-to-sales stands at 3.25 and EV/EBITDA is 12.51, suggesting that investors are willing to pay a significant multiple of sales and earnings before interest, taxes, depreciation, and amortization relative to the enterprise value. The 52-week high is $119.32 and the low is $96.95, meaning the current price sits within this historical range but requires calculation of the exact percentage distance from the highs or lows to determine precise positioning relative to volatility extremes. Beta is 0.65, which indicates that the stock's price volatility is significantly lower than the broader market, suggesting a defensive characteristic often found in insurance sectors during market downturns.
Growth & Income
Revenue growth is -9.9% and earnings growth is -22.9% year-over-year, showing that earnings are declining at a much faster rate than revenue, which implies that the company is facing significant margin compression or one-time costs impacting the bottom line disproportionately. As a dividend payer, the company offers a yield of 2.3% with a payout ratio of 34.0%, indicating that the payout is sustainable as it covers only a fraction of earnings, providing a buffer against earnings volatility. The low payout ratio allows the firm to retain a majority of its earnings for reinvestment or debt reduction rather than distributing all profits to shareholders. The overall growth and income profile presents a mix of current income support through dividends against a backdrop of recent double-digit declines in both revenue and earnings performance.